Madam Speaker, I appreciated my colleague's speech. We often work on the same files, including issues related to public safety and borders. We are interested in the same issues. I agree completely that there is a lack of transparency, a lack of consistency and, I would even add, a lack of leadership in how the vaccine supply is being managed. I am sure he will agree with me.
I doubt the Prime Minister is accustomed to calling up pharmaceutical companies when problems arise. Having to come up with solutions to the delays we are experiencing today seems to be new to him.
Why is it that countries like the United States can share the details of the contracts signed between the governments and the pharmaceutical companies? Why do we not have access to those details? This government lacks transparency. I would like to hear my colleague's opinion on that.